MCID: PLC009
MIFTS: 39

Placenta Praevia

Categories: Fetal diseases

Aliases & Classifications for Placenta Praevia

MalaCards integrated aliases for Placenta Praevia:

Name: Placenta Praevia 12 15 17 32
Placenta Previa 43 71

Classifications:



External Ids:

Disease Ontology 12 DOID:11060
MeSH 43 D010923
NCIt 49 C26858
SNOMED-CT 67 36813001
ICD10 32 O44 O44.1
UMLS 71 C0032046

Summaries for Placenta Praevia

Disease Ontology : 12 A placenta disease that is characterized by placenta attachment to the uterine wall close to or covering the cervix.

MalaCards based summary : Placenta Praevia, also known as placenta previa, is related to placenta accreta and asphyxia neonatorum. An important gene associated with Placenta Praevia is APEH (Acylaminoacyl-Peptide Hydrolase). The drugs Meperidine and Fentanyl have been mentioned in the context of this disorder. Affiliated tissues include placenta, uterus and cervix, and related phenotypes are adipose tissue and growth/size/body region

Wikipedia : 74 Placenta praevia is when the placenta attaches inside the uterus but in an abnormal position near or... more...

Related Diseases for Placenta Praevia

Diseases related to Placenta Praevia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 111)
# Related Disease Score Top Affiliating Genes
1 placenta accreta 31.0 PGF PAPPA OXT
2 asphyxia neonatorum 30.5 TMEM106C OXT APEH
3 neonatal anemia 30.3 SPTB PGF PAPPA
4 eclampsia 29.9 PGF PAPPA OXT
5 placenta disease 29.8 SPTB PGF PAPPA OXT APEH
6 pre-eclampsia 10.6
7 placental abruption 10.6
8 amenorrhea 10.4
9 varicose veins 10.4
10 chorioamnionitis 10.4
11 severe pre-eclampsia 10.4
12 infertility 10.4
13 thrombosis 10.3
14 endometritis 10.3
15 gestational diabetes 10.3
16 leiomyoma 10.3
17 cerebral palsy 10.3
18 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.3
19 deficiency anemia 10.3
20 endometriosis 10.3
21 pulmonary embolism 10.3
22 cervical incompetence 10.3 SPTB OXT
23 vaginal discharge 10.2 SPTB OXT
24 leiomyoma, uterine 10.2
25 systemic lupus erythematosus 10.2
26 afibrinogenemia, congenital 10.2
27 enterocolitis 10.2
28 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
29 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.2
30 limb ischemia 10.2
31 adult respiratory distress syndrome 10.2
32 periventricular leukomalacia 10.2
33 perinatal necrotizing enterocolitis 10.2
34 47,xyy 10.2
35 thrombocytopenic purpura, autoimmune 10.1
36 hydatidiform mole, recurrent, 1 10.1
37 ocular motor apraxia 10.1
38 respiratory distress syndrome in premature infants 10.1
39 thymoma, familial 10.1
40 pain agnosia 10.1
41 ectopic pregnancy 10.1
42 sarcoma 10.1
43 disseminated intravascular coagulation 10.1
44 hepatic coma 10.1
45 newborn respiratory distress syndrome 10.1
46 myoma 10.1
47 thymoma 10.1
48 purpura 10.1
49 gestational trophoblastic neoplasm 10.1
50 placental insufficiency 10.1

Graphical network of the top 20 diseases related to Placenta Praevia:



Diseases related to Placenta Praevia

Symptoms & Phenotypes for Placenta Praevia

MGI Mouse Phenotypes related to Placenta Praevia:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 adipose tissue MP:0005375 9.5 ARRB1 ARRB2 DACT3 OXT PGF SCARA5
2 growth/size/body region MP:0005378 9.28 ARRB1 ARRB2 DACT3 HCCS OXT PAPPA

Drugs & Therapeutics for Placenta Praevia

Drugs for Placenta Praevia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 113)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Meperidine Approved Phase 4 57-42-1 4058
2
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
3
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
4
Dinoprostone Approved Phase 4 363-24-6 5280360
5
Scopolamine Approved, Investigational Phase 4 6533-68-2, 51-34-3 5184
6
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
7
Acetaminophen Approved Phase 4 103-90-2 1983
8
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
9
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
10
Atropine Approved, Vet_approved Phase 4 51-55-8, 5908-99-6 174174
11
Oxytocin Approved, Vet_approved Phase 4 50-56-6 53477758 439302
12
Carbetocin Approved, Investigational Phase 4 37025-55-1 71715 16681432
13
Alprostadil Approved, Investigational Phase 4 745-65-3 149351 5280723
14
Bilirubin Phase 4 69853-43-6, 635-65-4 21252250 5280352
15 Anti-Arrhythmia Agents Phase 4
16 Anticonvulsants Phase 4
17 Gastrointestinal Agents Phase 4
18 Pharmaceutical Solutions Phase 4
19 Respiratory System Agents Phase 4
20 Anti-Asthmatic Agents Phase 4
21 Bronchodilator Agents Phase 4
22 Neurotransmitter Agents Phase 4
23 Parasympatholytics Phase 4
24 Cholinergic Agents Phase 4
25 Antiemetics Phase 4
26 Muscarinic Antagonists Phase 4
27 Cholinergic Antagonists Phase 4
28 Mydriatics Phase 4
29 Butylscopolammonium Bromide Phase 4
30 Bromides Phase 4
31 Ketorolac Tromethamine Phase 4
32 Antipyretics Phase 4
33 Cyclooxygenase Inhibitors Phase 4
34 Analgesics, Non-Narcotic Phase 4
35 Anti-Inflammatory Agents Phase 4
36 Antirheumatic Agents Phase 4
37 Anti-Inflammatory Agents, Non-Steroidal Phase 4
38 Dopamine Antagonists Phase 4
39 Dopamine Agents Phase 4
40
Nifedipine Approved Phase 3 21829-25-4 4485
41
Ergonovine Approved Phase 3 60-79-7 443884
42
Lactitol Approved, Investigational Phase 3 585-88-6, 585-86-4 493591
43
Tranexamic Acid Approved Phase 3 1197-18-8 5526
44
Melatonin Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 73-31-4 896
45 Calcium, Dietary Phase 3
46 calcium channel blockers Phase 3
47 Hormones Phase 3
48 Hormone Antagonists Phase 3
49 Progestins Phase 3
50 Hemostatics Phase 3

Interventional clinical trials:

(show top 50) (show all 133)
# Name Status NCT ID Phase Drugs
1 The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels .A Prospective Randomized Controlled Trial. Unknown status NCT02602301 Phase 4 Oxytocin
2 Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): A Randomized, Placebo-controlled Double Blind Trial Completed NCT02806024 Phase 4 Tranexamic Acid;Placebo Drug
3 Is There Any Effect of Meperidine on the Length of Duration of Labor? A Prospective Randomized Controlled Trial. Completed NCT01555671 Phase 4 Placebo;Meperidine
4 The Comparison of Hyperbaric Bupivacaine Plus Fentanyl and Hyperbaric Levobupivacaine Plus Fentanyl Administered Intrathecally in Patients Undergoing Elective Cesarean Section Completed NCT02025374 Phase 4 Hyperbaric levobupivacaine;Hyperbaric bupivacaine % 0.5
5 A Prospective Multi-centre Randomised Comparison on Induction of Labour With Double-balloon Installation Device Versus Prostaglandin E2 Minprostin Completed NCT01255839 Phase 4 Minprostin
6 Efficacy and Safety of Hyoscine N Butyl Bromide on the Augmentation of Labor: a Double-Blind, Placebo - Controlled Trial Completed NCT02098889 Phase 4 hyoscine-N-butyl bromide(HBB);Saline
7 Multimodal Pain Management for Cesarean Delivery: A Randomized Control Trial Completed NCT02922985 Phase 4 Intravenous acetominophen;Ketorolac, intramuscular;Bupivacaine, subcutaneous;Normal saline
8 Intrathecal Atropine Versus Intravenous Metoclopramide for Prevention of Nausea and Vomiting During Caesarian Section Under Spinal Anesthesia Completed NCT03932578 Phase 4 Atropine sulfate;Metoclopramide
9 Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Cases With Placenta Previa After C.S. Recruiting NCT02277041 Phase 4 Carbetocin;Misoprostol
10 Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Pregnant Women at High Risk Following C.S. Recruiting NCT02277067 Phase 4 Carbetocin;Misoprostol
11 Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial Unknown status NCT02303418 Phase 3 Carbetocin;Oxytocin
12 Oral Nifedipine Versus Intravenous Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa: Randomized Controlled Trial. Unknown status NCT03542552 Phase 3 Magnesium Sulfate;Nifedipine
13 Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial Unknown status NCT02410759 Phase 3 Carbetocin;Ergometrine
14 Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial Unknown status NCT02306733 Phase 3 Ergometrine;Oxytocin
15 Cervical Pessary vs. Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial Unknown status NCT02470676 Phase 2, Phase 3 Progesterone
16 Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa: A Randomized Controlled Trial Completed NCT03060889 Phase 3 Tranexamic acid
17 Lower Uterine Compression Sutures for the Treatment of Postpartum Hemorrhage Due to Placenta Previa Complete Centralis; Prospective Study Completed NCT02157441 Phase 2, Phase 3
18 Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta: A Randomized Clinical Trial Completed NCT03824873 Phase 3
19 Can we Use Intravenous Injection of Tranexamic Acid in Routine Practice With Active Management of the Third Stage of Labor? Completed NCT01338454 Phase 3 transamin
20 Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial Completed NCT02304055 Phase 3 Carbetocin;Oxytocin
21 Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial Completed NCT02304042 Phase 3 Carbetocin;Oxytocin
22 Comparison of the Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor Completed NCT02989519 Phase 3 dydrogesterone;Micronized progesterone
23 Efficacy of Antenatal Tranexamic Acid in Pregnant Women With Symptomatic Placenta Previa in Decreasing Antepartum Hemorrhage - A Randomized Controlled Trial Recruiting NCT04055194 Phase 2, Phase 3 Tranexamic acid tablets;Placebo oral tablet
24 TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA: a Multicenter Randomised, Double Blind Placebo Controlled Trial Not yet recruiting NCT04304625 Phase 3 Tranexamic Acid / Sodium chloride
25 Laparoscopic Repair Of Cesarean Scar Niche: Randomized Controlled Trial. Not yet recruiting NCT04307524 Phase 2, Phase 3 medical treatment in the form of combined hormonal contraception
26 Therapeutic Effects of Maternal Melatonin Administration on Brain Injury and White Matter Disease in Very Preterm Infants Terminated NCT02395783 Phase 2, Phase 3 Melatonin 10 µg;Melatonin 20 µg
27 Cerclage Placement for the Prevention of Preterm Birth in Women With Placenta Previa - A Multicenter Randomized Controlled Trial Withdrawn NCT01442207 Phase 3
28 Efficacy of Tranexamic Acid in Reducing Blood Loss During and After Caesarean Section Unknown status NCT02350179 Phase 1, Phase 2 Tranexamic Acid;Glucose
29 Maintenance Oral Nifedipine for Management of Symptomatic Placenta Previa : A Randomized Clinical Trial Completed NCT00620724 Phase 2 Placebo;Nifedipine
30 Efficacy of Tranexamic Acid In Reducing Blood Loss Among Pregnant Women During Cesarean Section Because Of Placenta Previa Completed NCT02688127 Phase 1, Phase 2 Tranexamic Acid
31 The Use Of Intramuscular Hydroxyprogesterone Caproate For Management Of Placenta Previa Before 34 Weeks Of Gestation Completed NCT03130504 Phase 2 17α hydroxy progesterone caproate
32 Random Placenta Margin Incision for Hemorrhage Control During Cesarean Section of Complete Placenta Previa Pregnancies Completed NCT02695069 Phase 2
33 Use of Foley's Catheter Balloon Tamponade to Control Placental Site Bleeding Resulting From Placenta Previa During Cesarean Section Completed NCT02640885 Phase 2
34 Efficacy of Prophylactic Vaginal Progesterone in Prevention of Preterm Delivery in Women With Placenta Previa Recruiting NCT03633175 Phase 2 Vaginal progesterone
35 Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor: A Randomized Controlled Trial Active, not recruiting NCT03523754 Phase 1, Phase 2 Isosorbide Mononitrate 40 MG to study group
36 Dexamethasone Effect on Induction Delivery Interval at Term Randomized Controlled Trial Completed NCT03658590 Phase 1 Dexamethasone;Distilled Water
37 ADAMTS, Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis(Accreta, Increta, Percreta) Unknown status NCT02270593
38 The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta: a Prospective Study Unknown status NCT02590484
39 Incidence of Placenta Accreta & it's Complications in Cases of Previous Cesarean With Placenta Previa Anterior Unknown status NCT02606474
40 Value of Third Trimester Cervical Length Measurement in Predicting Risk and Severity if Antepartum Haemorrhage in Cases of Placenta Previa Unknown status NCT03451136
41 Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta in a High Risk Population Unknown status NCT02784886
42 Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler in Cases of Placenta Accreta Unknown status NCT03530475
43 Comparison Between the Role of Transabdominal Ultrasound Versus Transvaginal Ultrasound in Evaluation of Placental Invasion in Cases of Placenta Previa Anterior Wall With Previous Uterine Scar Unknown status NCT03437291
44 Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa Unknown status NCT03124472
45 Predictors of Scar Dehiscence in Patients With Previous Caesarean Section; a Study of Different Variables Tenderness Versus Non-stress Test Unknown status NCT03140683
46 Antenatal Diagnosis of Placental Attachment Disorders Unknown status NCT02442518
47 New Surgical Technique To Control Postpartum Hemorrhage Due To Placenta Accreta Unknown status NCT03241849
48 Comparison Between the Use of Standard Oxytocin Induction Protocol and the Double-balloon Catheter Device With Concurrent Oxytocin Unknown status NCT01615107 PITOCIN
49 Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar With Doppler Assessment of Retro Chorionic Blood Flow Unknown status NCT03208842
50 Evaluation of the Active Warming Effects on Maternal and Neonatal Outcomes During Cesarean Delivery Unknown status NCT03473470

Search NIH Clinical Center for Placenta Praevia

Cochrane evidence based reviews: placenta previa

Genetic Tests for Placenta Praevia

Anatomical Context for Placenta Praevia

MalaCards organs/tissues related to Placenta Praevia:

40
Placenta, Uterus, Cervix, Testes, Brain, Thyroid, Colon

Publications for Placenta Praevia

Articles related to Placenta Praevia:

(show top 50) (show all 3294)
# Title Authors PMID Year
1
Laterally-positioned placenta in placenta previa. 61
30518276 2020
2
The role of supracervical hysterectomy in reducing blood products requirement in the management of placenta accreta: a case-control study. 61
30486702 2020
3
Blunt dissection technique with finger and vessel skeletonization in the posterior vesical wall for abnormally invasive placenta previa. 61
30486701 2020
4
Safety and Efficacy of Aortic Vs Internal Iliac Balloon Occlusion for Cesarean Delivery in Coexisting Placenta Accreta and Placenta Previa. 61
32533311 2020
5
The efficacy between cervical-lifting suture and lower B-Lynch suture in placenta previa: a retrospective cohort-study. 61
32500216 2020
6
The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study. 61
32513127 2020
7
The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum. 61
32542670 2020
8
Uterine electromyography (EMG) measurements to predict preterm caesarean section in patients with complete placenta previa. 61
32496884 2020
9
Efficacy of intraoperative wireless ultrasonography for uterine incision among patients with adherence findings in placenta previa. 61
32207196 2020
10
Predicting risk of postpartum haemorrhage: a systematic review. 61
32575159 2020
11
Exercise during pregnancy: how much active are pregnant women at risk of gestational diabetes despite few contraindications? 61
32490696 2020
12
Uterine artery Doppler velocimetry at mid-term gestation as a potential predictive factor for the resolution of placenta previa at the end of third trimester of pregnancy. 61
32281243 2020
13
Maternal and Neonatal Hospitalization Costs Associated With Elective Induction of Labor at Term in California, 2007-2011. 61
32541294 2020
14
Emergency-release blood transfusions after postpartum hemorrhage at the Intermountain Healthcare hospitals. 61
32529673 2020
15
Placenta Accreta Spectrum: Correlation of MRI Parameters With Pathologic and Surgical Outcomes of High-Risk Pregnancies. 61
32208011 2020
16
Suspected Placenta Accreta: Using Imaging to Stratify Risk of Morbidity. 61
32512608 2020
17
Uterine body placenta accreta spectrum: A detailed literature review. 61
32452401 2020
18
Pregnancy and neonatal outcomes of women with disabilities: a nationwide population-based study in South Korea. 61
32514114 2020
19
IVF/ICSI treatment and the risk of iatrogenic preterm birth in singleton pregnancies: systematic review and meta-analysis of cohort studies. 61
32498576 2020
20
Internal Iliac Artery Balloon Occlusion for Placenta Previa and Suspected Placenta Accreta: A Randomized Controlled Trial. 61
32282608 2020
21
[Clinical investigation in the methods for complete placenta previa labor induction in the second trimester]. 61
32464719 2020
22
Cervical pessary for preterm twin pregnancy in women with a short cervix. 61
32489967 2020
23
Obstetric hemorrhage and risk of cardiovascular disease after three decades: A population-based cohort study. 61
32418291 2020
24
Determinants of cesarean-related complications: high number of repeat cesarean, operation type or placental pathologies? 61
32429719 2020
25
Antepartum Hemorrhage and Outcome of Very Low Birth Weight, Very Preterm Infants: A Population-Based Study. 61
32446258 2020
26
Clinical outcomes and anesthetic management of pregnancies with placenta previa and suspicion for placenta accreta undergoing intraoperative abdominal aortic balloon occlusion during cesarean section. 61
32473651 2020
27
Pregnancy outcomes in women with history of surgery for endometriosis. 61
32327240 2020
28
Prospective First-Trimester Ultrasound Imaging of Low Implantation and Placenta Accreta Spectrum. 61
32374433 2020
29
A retrospective review of 10-year trends in general anesthesia for cesarean delivery at a university hospital: the impact of a newly launched team on obstetric anesthesia practice. 61
32404093 2020
30
Endometriosis Is Associated with Adverse Pregnancy Outcomes: a National Population-Based Study. 61
31953772 2020
31
Tobacco and Nicotine Cessation During Pregnancy: ACOG Committee Opinion Summary, Number 807. 61
32332411 2020
32
Tobacco and Nicotine Cessation During Pregnancy: ACOG Committee Opinion, Number 807. 61
32332417 2020
33
Reproductive and Obstetric Outcomes After Hysteroscopic Removal of Retained Products of Conception. 61
31352066 2020
34
Risk factors for severe postpartum haemorrhage during caesarean section for placenta praevia. 61
31476931 2020
35
The risk of adverse maternal outcomes in cases of placenta praevia in an Australian population between 2007 and 2017. 61
32372412 2020
36
A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. 61
31730756 2020
37
Effect of previous placenta previa on outcome of next pregnancy: a 10-year retrospective cohort study. 61
32293318 2020
38
Prophylactic uterine artery embolization during cesarean delivery for placenta previa complicated by placenta accreta. 61
31778209 2020
39
Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta. 61
31503353 2020
40
Outcome of multiple cesarean sections in a tertiary maternity hospital in the United Arab Emirates: A retrospective analysis. 61
32113061 2020
41
Is there an Increased Risk for Unfavorable Obstetric Outcomes in Women with Endometriosis? An Evaluation of Evidences. 61
32330962 2020
42
Maternal and neonatal outcomes of abnormal placentation: a case-control study. 61
32316780 2020
43
Evaluation of perioperative complications using a newly described staging system for placenta accreta spectrum. 61
32387893 2020
44
Endometrial thickness is associated with incidence of small-for-gestational-age infants in fresh in vitro fertilization-intracytoplasmic sperm injection and embryo transfer cycles. 61
32147172 2020
45
The impact of male infertility or intracytoplasmic sperm injection technique on perinatal outcomes. 61
32295443 2020
46
Prevalence and risk factors of preterm birth in Pakistan. 61
32296198 2020
47
[Adverse obstetric and perinatal outcome with in vitro fertilization technology: A French nationwide population-based study]. 61
32058045 2020
48
In vitro fertilization as an independent risk factor for placenta accreta spectrum. 61
32360847 2020
49
Antenatal Diagnosis of Marginal and Velamentous Placental Cord Insertion and Pregnancy Outcomes. 61
32168213 2020
50
Prognosticators of intravoxel incoherent motion (IVIM) MRI for adverse maternal and neonatal clinical outcomes in patients with placenta accreta spectrum disorders. 61
32420131 2020

Variations for Placenta Praevia

Expression for Placenta Praevia

Search GEO for disease gene expression data for Placenta Praevia.

Pathways for Placenta Praevia

GO Terms for Placenta Praevia

Cellular components related to Placenta Praevia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 postsynaptic membrane GO:0045211 8.8 CHRND ARRB2 ARRB1

Biological processes related to Placenta Praevia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endocytosis GO:0006897 9.58 SCARA5 ARRB2 ARRB1
2 positive regulation of protein phosphorylation GO:0001934 9.5 PGF ARRB2 ARRB1
3 negative regulation of interleukin-6 production GO:0032715 9.37 ARRB2 ARRB1
4 positive regulation of receptor internalization GO:0002092 9.26 ARRB2 ARRB1
5 G protein-coupled receptor internalization GO:0002031 9.16 ARRB2 ARRB1
6 female pregnancy GO:0007565 9.13 PGF PAPPA OXT
7 follicle-stimulating hormone signaling pathway GO:0042699 8.62 ARRB2 ARRB1

Molecular functions related to Placenta Praevia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 arrestin family protein binding GO:1990763 9.32 ARRB2 ARRB1
2 alpha-1B adrenergic receptor binding GO:0031692 9.26 ARRB2 ARRB1
3 follicle-stimulating hormone receptor binding GO:0031762 9.16 ARRB2 ARRB1
4 angiotensin receptor binding GO:0031701 8.96 ARRB2 ARRB1
5 alpha-1A adrenergic receptor binding GO:0031691 8.62 ARRB2 ARRB1

Sources for Placenta Praevia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....